Get MLR out of the bottleneck. Get science out the door.
Medical, Legal & Regulatory review isn't slow because your writers are slow — it's slow because every claim needs a human to hunt down the source. VarsaAI hunts first, so review becomes confirmation, not investigation.
AI didn't fix your review queue. It made it bigger.
Generative AI is now drafting everything — HCP emails, MOA decks, MSL response letters, congress abstracts, payer dossiers. Volume up. Sourcing burden? Up further.
Every AI-generated sentence still has to be traced back to approved labelling, published literature, or the CSR — by a human, at their desk, one claim at a time. The MLR queue that already ran hot is now buried under content nobody can prove is safe to publish.
The workaround most teams have quietly adopted — 'let the AI draft it, we'll fact-check it later' — is exactly the workflow regulators, auditors and your own compliance function are least willing to accept. And in Europe, the EU AI Act adds a documentation obligation on top: you now need an evidence trail for every AI-assisted output in a high-risk use case, including pharmaceutical communications.
The scarce resource in your organisation isn't AI capacity. It's the reviewer's attention. VarsaAI protects it.
Ask yourself, honestly.
How many hours per week do your reviewers spend hunting sources instead of reviewing science?
In most teams, it's the majority of their day. Sourcing is not the value they add — judgement is.
Could you produce a full evidence trail for every AI-assisted piece of content published in the last 12 months?
If the answer is 'we'd have to reconstruct it,' you don't have one.
What percentage of PRC rejections are content issues vs sourcing issues?
Most are sourcing. VarsaAI removes that category of rejection entirely.
How much of your MSL response time is 'let me get back to you'?
Every 'get back to you' is a moment of lost trust with the HCP — and it usually resolves into a manual sourcing exercise anyway.
What one unverified claim can cost you.
Regulatory action on unsubstantiated claims
FDA OPDP, MHRA and EMA continue to issue enforcement letters on off-label promotion and unsubstantiated efficacy claims. An AI-generated claim with no traceable source is exactly the failure mode they're looking for.
EU AI Act non-compliance
From August 2, 2026 GPAI providers and deployers in high-risk use cases must produce documentation on demand. Pharma communications are squarely in scope. No audit trail, no defence.
Reviewer burnout and attrition
Senior medical reviewers are quitting because their job has become citation-chasing. Replacing them costs 12–18 months of institutional knowledge.
Speed-to-market lost to internal review
Every day content sits in MLR is a day competitors are in front of the HCP instead of you. Launch windows don't wait for your queue.
Silent PV signals inside generated content
AI drafting a safety-adjacent sentence without ground truth can materially misstate risk. That's not a marketing issue — it's a pharmacovigilance one.
How the workflow changes when VarsaAI is inside your AI Engine.
Writer prompts Claude → gets fluent draft → manually maps each claim back to labelling, CCDS, or literature.
Writer prompts Claude → VarsaAI grounds each claim against approved sources before generation → draft arrives with sources already attached.
Reviewer opens draft, opens PubMed, opens the label, opens the CSR, cross-checks every sentence.
Reviewer opens draft with every claim pre-linked to its source. Judgement in minutes, not days.
Committee spends the meeting debating whether claim X is on-label.
Committee sees claim X with the exact label section attached. Meeting becomes a rubber stamp.
Team scrambles to reconstruct provenance for content published 9 months ago.
Exportable audit trail — prompt, sources, checks, edits, sign-off — pulled in seconds.
Real outcomes Life Sciences teams get when generation is grounded.
Review becomes confirmation, not investigation.
Because sourcing is done at draft, reviewer time collapses to judgement calls only.
Nothing ungrounded reaches PRC.
VeriCore™ blocks generation of claims that don't map to an approved source.
Every generation logs itself.
Prompt, retrieved sources, claim checks, edits and approvals — timestamped and exportable.
Weeks recovered per campaign.
The compression of MLR is the single biggest lever on speed-to-HCP.
PRC returns collapse.
Content arrives pre-cleared on the dimension PRC rejects on most: sourcing.
Give experts their job back.
Reviewers do medicine, not librarianship. Attrition risk drops.
What changes on Monday morning.
MLR Reviewers
Days per submission, most of it citation-chasing.
Minutes per submission, spent on scientific judgement.
Medical Writers
Draft, then rework citations three times before sign-off.
Draft with sources auto-attaching in real time.
MSLs
'Let me get back to you on that MOA question.'
Answer on the spot — verified source attached.
Medical Information
Standard response letters re-verified every audit cycle.
Every SRL is audit-ready the moment it's written.
Regulatory Affairs
Deadline-week scramble to sourcing everything.
Sourcing is already done — submission week is calm.
Pharmacovigilance
Safety-adjacent claims caught downstream, if at all.
Safety claims checked against source before anyone acts.
Publications
Journal revisions on citation accuracy.
Manuscripts clear scrutiny first time.
HEOR
Payer challenge on a stat you can't quickly source.
Every number traceable to a named study, instantly.
PRC
Bottleneck committee.
Approval body.
Compliance
No systematic AI-content audit trail.
Permanent, exportable evidence for every AI-assisted claim.
The ROI is measured in reviewer weeks, launch days, and enforcement letters that never arrive.
- ✓MLR cycle time reduced 70–90%.
- ✓PRC rejection rate on sourcing issues → near zero.
- ✓Full EU AI Act evidence trail — no additional headcount.
- ✓Launch content out weeks earlier per campaign.
- ✓Medical reviewers retained because they're doing medicine again.
- ✓Every claim your company has ever AI-generated becomes searchable and defensible.
Your team is already using Claude and ChatGPT to draft. Make sure every claim is provable before it reaches a reviewer.
VarsaAI plugs into your existing AI Engine via MCP — no new platform to adopt, no workflow change for your writers.